1-14 of 14
Samuel Yamshon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin (P-GVD) for Classical Hodgkin Lymphoma (CHL) in the Real-World Setting

Grace T. Baek, Gaurav Varma, Samuel Yamshon, Herman van Besien, Nancy L. Bartlett, Marcus P. Watkins, Harsh R. Shah, Kelsey Baron, Reid W. Merryman, Ayo S Falade, Jakub Svoboda, Sara Prischak, Christopher R D'Angelo, Joe D. Lukowski, Ranjana H. Advani, Austin H. Yeung, Maya C. Rosenberg, Jenna M. Voutsinas, Mengyang Di, Ryan C Lynch, Christina Poh, Vikram Raghunathan, Mazyar Shadman, Stephen D. Smith, Brian G. Till, Chaitra S. Ujjani, Catherine S. Diefenbach, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 4431.
https://doi.org/10.1182/blood-2024-200719
Published: 2024
Journal Articles

A Balancing Act: Outcomes of Post-Transplant Cyclophosphamide in Older Patients

Herman Van Besien, Samuel Yamshon, Alexandra Gomez-Arteaga, Nora Chokr, Sebastian A. Mayer, Michelle S Pasciolla, Rachel Abramova, Tsiporah B. Shore, Juliet N Barker, Anna Alperovich
Journal: Blood
Blood (2024) 144 (Supplement 1): 7375.
https://doi.org/10.1182/blood-2024-211361
Published: 2024
Journal Articles

Absolute Lymphocyte Count after CAR-T Therapy Has Different Kinetics and Predicts Better Outcomes in B-Cell Malignancies

Juan Esteban Velez-Hernandez, Mateo Mejia Saldarriaga, Caitlin Unkenholz, Christian A Gordillo, Divaya Bhutani, Roger Pearse, Rajshekhar Chakraborty, Suzanne Lentzsch, Markus Y Mapara, Ruben Niesvizky, Ran Reshef, Samuel Yamshon, Mark Bustoros
Journal: Blood
Blood (2024) 144 (Supplement 1): 7160.
https://doi.org/10.1182/blood-2024-209960
Published: 2024
Journal Articles

Concomitant Use of Antibiotics During Immune Checkpoint Inhibitor (CPI)-Based Salvage Therapy Does Not Impact Post-ASCT Outcomes in Patients with Relapsed/Refractory Hodgkin Lymphoma (RRHL)

Gaurav Varma, Maya C. Rosenberg, Erica C. Agbadiba, Austin H. Yeung, Ayo S. Falade, Marcus P. Watkins, Grace T. Baek, Herman van Besien, Kelsey Baron, Meghana K. Subramanian, Sara Prischak, Joe D. Lukowski, Christopher D'Angelo, Jakub Svoboda, Joanna M. Rhodes, Harsh R. Shah, Samuel Yamshon, Ajay K. Gopal, Nancy L. Bartlett, Reid W. Merryman, Ranjana H. Advani, Sairah Ahmed, Catherine S. Diefenbach
Journal: Blood
Blood (2024) 144 (Supplement 1): 4425.
https://doi.org/10.1182/blood-2024-197923
Published: 2024
Journal Articles

Treatment Patterns and Outcomes Following Progression of Disease Post-CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter Analysis

Zachary D. Epstein-Peterson, Anath C. Lionel, Ashlee Joseph, Esther Drill, Suheil Albert Atallah-Yunes, Taylor R. Brooks, Elise A. Chong, Emeline R. Chong, Jamie Dela Cruz, Matthew J. Frank, Andrew Ip, Madiha Iqbal, Caron A. Jacobson, Manali K. Kamdar, Reem Karmali, Kami J. Maddocks, Matthew Matasar, Reid W. Merryman, Javier Munoz, Peter A. Riedell, Christine E. Ryan, Gilles Salles, Craig S. Sauter, Yazeed Sawalha, Roni Shouval, Navika Shukla, Alexander V. Stanisic, Dylan Therwhanger, Herman Van Besien, Yucai Wang, Samuel Yamshon, Andrew D. Zelenetz, Maria Lia Palomba, Preetesh Jain, Anita Kumar
Journal: Blood
Blood (2024) 144 (Supplement 1): 238.
https://doi.org/10.1182/blood-2024-192995
Published: 2024
Journal Articles

Non-White and Hispanic Patients Have Significantly Longer Time from Intent to CAR T Infusion (“Brain-to-Vein” Time) in Multiply Relapsed Diffuse Large B Cell Lymphoma

Neela Easwar, Anna Alperovich, Alexandra Gomez-Arteaga, Sebastian A. Mayer, Nora Chokr, Adrienne A. Phillips, Jingmei Hsu, Koen van Besien, Matthew Gromowsky, Matthew Lunning, Tsiporah B. Shore, Juliet N Barker, Samuel Yamshon
Journal: Blood
Blood (2024) 144 (Supplement 1): 2351.
https://doi.org/10.1182/blood-2024-201337
Published: 2024
Journal Articles

Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with R-GemOx: A Multi-Center Retrospective Cohort Study

Samuel Yamshon, Jean L. Koff, Melissa C. Larson, Brad S. Kahl, Carla Casulo, Izidore S. Lossos, Sara Haddadi, Michele D. Stanchina, Dai Chihara, Amy A. Ayers, Thomas M. Habermann, Yucai Wang, Arushi Khurana, Grzegorz S. Nowakowski, Tanner W Reicks, Umar Farooq, Brian K. Link, Jonathon B. Cohen, Peter Martin, Jia Li, Ashwini Shewade, Connie Lee Batlevi, Andrea Lo-Rossi, David Fox, Anthony Masaquel, Yong Mun, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Loretta Nastoupil
Journal: Blood
Blood (2024) 144 (Supplement 1): 3093.
https://doi.org/10.1182/blood-2024-208111
Published: 2024
Journal Articles

Axicabtagene Ciloleucel in Patients Aged 75 and Older: A Retrospective Cohort Study

Neela Easwar, Joshua Fein, Michelle S Pasciolla, Rachel Abramova, Tsiporah B. Shore, Samuel Yamshon
Journal: Blood
Blood (2023) 142 (Supplement 1): 6318.
https://doi.org/10.1182/blood-2023-178187
Published: 2023
Journal Articles

Low Dose Total Body Irradiation Improves CD19 CAR-T Expansion, Persistence, and Trafficking, Leading to Enhanced Efficacy in Large B-Cell Lymphoma

Mohammad Alhomoud, Michelle Foley, Mayumi Sugita, Takahiro Yamazaki, Leandro Martinez, Samuel Yamshon, Alexandra Gomez-Arteaga, Paul Pagnini, Tsiporah B. Shore, Olivier Boyer, Renier Brentjens, Koen Van Besien, Lorenzo Galluzzi, Silvia Formenti, Jeremie Martinet, Monica L. Guzman
Journal: Blood
Blood (2023) 142 (Supplement 1): 1016.
https://doi.org/10.1182/blood-2023-185216
Published: 2023
Journal Articles

Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel

Jason T. Romancik, Subir Goyal, James N Gerson, Hatcher J Ballard, Yazeed Sawalha, David A. Bond, Michael Joseph Rogalski, Irl Brian Greenwell, Koen van Besien, Samuel Yamshon, Reem Karmali, Imran Nizamuddin, Pallawi Torka, Victor A. Chow, Mazyar Shadman, Nilanjan Ghosh, Tamara K. Moyo, Timothy S. Fenske, Alexandra Rezazadeh, Natalie S Grover, Kami J. Maddocks, Caron Jacobson, Jonathon B. Cohen
Journal: Blood
Blood (2021) 138 (Supplement 1): 1756.
https://doi.org/10.1182/blood-2021-153277
Published: 2021
Journal Articles

Initial Treatment with Lenalidomide Plus Rituximab for Mantle Cell Lymphoma (MCL): 7-Year Analysis from a Multi-Center Phase II Study

Samuel Yamshon, MD, Peter Martin, FRCPC, MD MS, Bijal Shah, MD, Stephen J. Schuster, MD, Paul J Christos, Dr.P.H., M.S., Amelyn Rodriguez, BSN, RN, OCN, Sonali M. Smith, MD, Jakub Svoboda, MD, Richard R. Furman, MD, Sarah C. Rutherford, MD, John N. Allan, MD, John P. Leonard, MD, Jia Ruan, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-138731
Published: 2020
Journal Articles

Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset

Samuel Yamshon, MD, Miguel Dario Cantu, Ethel Cesarman, MD PhD, Sarah C. Rutherford, MD, Amy Chadburn, MD, Genevieve Marie Crane, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2792.
https://doi.org/10.1182/blood-2019-128374
Published: 2019
Journal Articles

Venous Thromboembolism in Patients with B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Lenalidomide

Samuel Yamshon, MD, Michelle Demetres, BA, Hoda Hammad, MS, MPH, Paul J Christos, Dr.P.H., M.S., John P. Leonard, MD, Jia Ruan, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 221.
https://doi.org/10.1182/blood.V130.Suppl_1.221.677
Published: 2017
Journal Articles

Correlative Analysis and Clinical Update Of a Phase II Study Using Lenalidomide and Rituximab In Patients With Indolent Non-Hodgkin Lymphoma

Samuel Yamshon, Lihong Qi, PhD, Chaoyu Yu, Xiao-Dong Li, PhD, Robert O'Donnell, MD, PhD, Joseph Tuscano, MD
Journal: Blood
Blood (2013) 122 (21): 249.
https://doi.org/10.1182/blood.V122.21.249.249
Published: 2013